Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Daptomycin manufacturers

17 products found

Filters

17 products found

daptomycin

Injection, lyophilized 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Manufacturer #298

Manufacturer usually replies in 5 days

daptomycin

Vials, lyophilized injection 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 7 days

daptomycin

Vials, injection 350mg/ml, 500mg/ml - 20ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 7 days

daptomycin

Powder for solution for injection/infusion 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: CubicinĀ®Merck
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

daptomycin

Solution for injection 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, TGA, WHO
Registered in
Austria , Cyprus , France , Germany , Greece , Spain , United Kingdom
Available for
Licensing with supply
Manufacturer #12792

Manufacturer usually replies in 6 days

daptomycin

Injection 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #615

Manufacturer usually replies in 3 days

daptomycin

Solution for injection 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #8228

Manufacturer usually replies in 2 days

daptomycin

Vials, injection 350mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #1187

daptomycin

Vials, injection 350mg, 500mg - 10ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #11531

Manufacturer usually replies in 6 days

daptomycin

Vials, injection 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

daptomycin

Vials, injection 350 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18038
The primary mission of the company is to create new values to protect the lives and health of humankind and to improve the quality of life. They are striving to develop the world's leading new drugs through bold investments and cutting-edge research facilities.

Manufacturer usually replies in 5 days

daptomycin

Vials, lyophilized injection 350mg, 500mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
Turkey
Manufacturer #10966
It is a well-known international pharmaceutical company with operations in more than 15 countries. Orphan illness, plasma products, hospital injectables, vaccines, and particular OTC products are among the company's specialties. The company, which believes that every patient deserves current treatment options and a great quality of life, formed its R&D department in the 2010s and has been working hard since to develop and produce specialized products.

Manufacturer usually replies in 8 days

daptomycin

Injection 350mg,500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #8101

Manufacturer usually replies in 29 days

daptomycin

Injection 350 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

Manufacturer usually replies in 14 days

daptomycin

Vials, injection 500mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, TGA
Manufacturer #17216

Manufacturer usually replies in 19 days

daptomycin

Powder for solution for injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

daptomycin

Vials 350 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430

Manufacturer usually replies in nan days

What is the drug Daptomycin?

Daptomycin is a lipopeptide antibiotic. It is used to treat bacterial infection of the skin caused by gram-positive microorganisms, Staphylococcus aureus, and bloodstream infection. It is administered only by intravenous processes. Daptomycin is a natural compound found in the saprotroph soil. Daptomycin was the first lipopeptide antimicrobial medication to be marketed. Today, it represents 83 % of in vitro antibiotics for gram-positive infections. Dasatinib medication is generally used to replace Gleevec when it is no longer efficient on patients or when the patients suffer from too strong side effects.

Wholesalers and manufacturers of Daptomycin

Daptomycin suppliers marketed it in the form of powder or injection for solutions. The medication is available either by its generic name, Daptomycin, first launched by Teva or by its brand name Cucibin marketed by Cubist Pharmaceuticals. Daptomycin was approved to be marketed in 2003 in the United States and in 2006 in the European Union.
The medication can be manufactured by Pfizer, Merck, and many others thanks to partnerships with Cubist. Counting only in China, there are more than 230 Daptomycin suppliers.

Daptomycin for sale:

The retail prices for one dose of Daptomycin intravenous powder for injection for 350 mg can fluctuate from $60 to $240, and for one dose of 500 mg, it can cost from $85 to $175, in the US market.
On Pipelinepharma online B2B marketplace, Daptomycin is mostly available from Turkey, where the medication was discovered. The platform helps Daptomycin distributors to find globally qualified manufacturers through quality control procedures. On the company website, you can find a list of many pharmaceutical products, including Daptomycin. If you are interested in this product, you can easily place an order on the Pipelinepharma platform to find Daptomycin manufacturers.

How to use Daptomycin drugs?

Depending on the Daptomycin treatment you follow, the use of the medication will be different. Taking Daptomycin for a skin and structure infection, an adult should take 4 mg/kg in vitro every 24 hours for 7 to 14 days.
If it is to treat Bacteremia, an adult should take 6 mg/kg IV every 24 hours for 2 to 6 weeks.
Daptomycin medication can have some side effects, the most common ones are: swelling of some body parts such as the face, arms, hands, lower legs, or feet, a fever, a rapid and unusual gain or loss of weight.
It must be stored in the refrigerator. If Daptomycin is mixed with a diluent, it still must be stored in the refrigerator but It must be taken within the following 48 hours.